Back to Search Start Over

Validating blood microsampling for per- and polyfluoroalkyl substances quantification in whole blood.

Authors :
Partington, Jordan M.
Marchiandi, Jaye
Szabo, Drew
Gooley, Andrew
Kouremenos, Konstantinos
Smith, Fraser
Clarke, Bradley O.
Source :
Journal of Chromatography A. Jan2024, Vol. 1713, pN.PAG-N.PAG. 1p.
Publication Year :
2024

Abstract

• Blood microsampling device validated for quantification of 72 PFAS. • Microsampling requires minimal handling and method simplicity for PFAS analysis. • Microsampling allows for straightforward analyte extractions from whole blood. • Useful tool for large scale human biomonitoring studies. Microsampling allows the collection of blood samples using a method which is inexpensive, simple and minimally-invasive, without the need for specially-trained medical staff. Analysis of whole blood provides a more holistic understanding of per- and polyfluoroalkyl substances (PFAS) body burden. Capillary action microsamplers (Trajan hemaPEN®) allow the controlled collection of whole blood as dried blood spots (DBS) (four 2.74 µL ± 5 %). The quantification of 75 PFAS from DBS was evaluated by comparing five common extraction techniques. Spiked blood (5 ng/mL PFAS) was extracted by protein precipitation (centrifuged; filtered), acid-base liquid-liquid extraction, trypsin protease digestion, and weak anion exchange (WAX) solid-phase extraction with analysis by high-performance liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). Filtered protein precipitation was the most effective extraction method, recovering 72 of the 75 PFAS within 70 to 130 % with method reporting limit (MRL) for PFOS of 0.17 ng/L and ranging between 0.05 ng/mL and 0.34 ng/mL for all other PFAS. The optimised method was applied to human blood samples to examine Inter- (n = 7) and intra-day (n = 5) PFAS blood levels in one individual. Sixteen PFAS were detected with an overall Σ 16 PFAS mean = 6.3 (range = 5.7–7.0) ng/mL and perfluorooctane sulfonate (branched and linear isomers, ΣPFOS) = 3.3 (2.8–3.7) ng/mL being the dominant PFAS present. To the authors knowledge, this minimally invasive self-sampling protocol is the most extensive method for PFAS in blood reported and could be a useful tool for large scale human biomonitoring studies. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00219673
Volume :
1713
Database :
Academic Search Index
Journal :
Journal of Chromatography A
Publication Type :
Academic Journal
Accession number :
174606071
Full Text :
https://doi.org/10.1016/j.chroma.2023.464522